On World Malaria Day, Dr Aubrey Cunnington’s daughter spends the day at his lab to learn how his team’s research is contributing to tackling malaria.
25 April is a special day in my calendar this year for two reasons. First, it is World Malaria Day – a chance for malaria researchers and many others to unite to raise awareness of this dreadful disease which kills over 400,000 people every year. Second, it is “Take Your Daughter to Work Day” for my 13-year old’s school, and she has chosen to spend the day with me at Imperial College London. I’m flattered but I’m also worried, because she can be my harshest critic, and on World Malaria Day I want to convince her (and everyone else) that my research is making a difference against malaria.
So what will it take to impress my 13-year old daughter, and perhaps give her the confidence and inspiration for a career? Looking for help, I ask my research team how they would explain their work to a 13-year old. Despite worried expressions, they are all up for giving it a go. (more…)
Ellen Grimas draws on her PhD research investigating the role of coparenting in children’s development and behaviour.
I remember a child psychiatrist saying during a keynote at a conference that the only mental health that mattered was child mental health. This made me think back to working at a mental health crisis house, where I was often struck by how many people said their symptoms first emerged in childhood or adolescence. Research tells a similar story, with recent figures suggesting that 75% of mental health problems emerge before the age of 18, and yet only 30% of people reported receiving proper and timely support.
This is worrying as there is a wealth of research suggesting that early intervention is not only beneficial for the individual and their family, but also for society as a whole. Childhood is clearly a key period in the development of our mental health, and also offers a unique opportunity to intervene. So, although it may not be the only mental health that matters, it is evidently an incredibly important component. In the context of an over-stretched NHS, the idea of low-level interventions in childhood that could help avoid the need for services in later life is a powerful one. (more…)
Dr Aaron Lett and Professor Gary Frost explain how Imperial is leading initiatives to address undernutrition in low-middle income countries.
Undernutrition is still a big problem in 2019.
Of the 5.6 million child deaths which occur globally, it is estimated 45% of them can be attributed to undernutrition. The majority of undernutrition occurs in low- and middle-income countries (LMICs) and manifests as stunting, wasting, and underweight.
The World Health Organisation (WHO) reports that today, 155 million children under five years are stunted, 52 million children are wasted, and 17 million are severely wasted. In addition to the negative health impact, undernutrition has significant economic and social implications on these LMICs. Despite current treatments that aim to reverse the nutritional status of individuals with undernutrition, there is still significant morbidity and mortality.(more…)
To mark National Obesity Awareness Week, Professor Tricia Tan explains how new research is harnessing the power of hormones to treat obesity more effectively.
Obesity has been an issue for centuries. However, it has transformed from a disease that once only touched a small number of people to a major health concern that currently affects one in four adults in the UK. As a result, obesity is now always in the news. Although many obese people are reasonably healthy, we know that obesity increases the risks of developing heart disease, diabetes mellitus (high blood sugar), cancer, respiratory problems (such as sleep apnoea and asthma) and arthritis. Obesity and its related health problems threaten to reverse the gains in lifespan that we have seen through the 20th century. So, how can we begin to tackle it? (more…)
Ahead of the recent G20 Summit in Buenos Aires, Professor Alison Holmes explained in an article for G20 Magazine why global collaboration is essential to minimising the impact of antimicrobial resistance (AMR) on healthcare.
The world faces the unprecedented challenge of drug resistant infection due to increasing AMR. Concerted global action is needed to address this pressing and alarming public health issue. Without a strong, unified response, the UN’s Sustainable Development Goals (SDGs) will not be met, and valuable progress will be lost.
The need for leadership
The continued inclusion of AMR in the G20 agenda, under the leadership of Argentina, is greatly welcomed. This year I was invited to speak in Buenos Aires on initiatives to optimise antibiotic use, at the International Congress on Infectious Diseases, co-hosted by the Infectious Diseases Society of Argentina. The ethos of shared learning and strong leadership was central in our discussions, and considered fundamental to effective action. (more…)
In this post, Dr Sujata Sridharan shares her career path, from graduating with an astrophysics degree to being a postdoc in brain imaging.
I’m not a scientist, not really. At least, that’s what I’ve heard countless times from my non-academic friends, and sometimes even colleagues. I’ve deduced that this belief dates back to my decision to take an MPhys in Physics with Astrophysics as my undergraduate degree.
As a (comparatively) fresh-faced 18-year-old, I undertook my first degree at the University of Manchester, (somewhat naively) under the impression that astrophysics involved a lot of actual stargazing. My first year was a pleasant 60:40 split of lectures and laboratory-based work. Albeit the latter was rather generalised; at one point I remember making a hologram of a bronze Buddha statue for no apparent scientific reason. My main concern at that point was that I hadn’t yet bumped into Brian Cox, who had recently taken up teaching duties at the university in between – what we physicists considered – glamorous filming of the ‘Wonders of the Universe’ documentary series. (more…)
200 years on from the first successful human-to-human blood transfusion, this procedure has revolutionised patient care. However, there is still work to be done in sub-Saharan Africa, as Professor Kathryn Maitland explains.
Each year, around 2.5 million units of blood are transfused in the UK – that’s enough to fill two Olympic sized swimming pools! Since James Blundell performed the first successful human blood transfusion in 1818, this life-saving medical intervention has made many advances to ensure its accessed throughout the world. An important part of this is ensuring that any health system has adequate supplies of quality-assured and safe blood for transfusion through national and regional blood transfusion services (BTS). (more…)
In this post, Dr Richard Kelwick explores exosomes – the tiny vesicles that may hold great therapeutic potential.
The adult human body is composed of around 30 trillion cells! That’s a lot of cells, and researchers are still figuring out the remarkable processes that govern how our cells are exquisitely organised into the complex tissues, organs and systems that make up our bodies. In order for our cells to co-ordinate and organise themselves correctly they need to be able to communicate with each other at the molecular level. Cells can communicate with each other using a variety of different ways, either by physically tugging on neighbouring cells, or by secreting proteins, hormones and many other types of signalling molecules. Cells can also send exosomes to each other. (more…)
For World Hepatitis Day, Dr Ana Ortega-Prieto explains why she switched her research focus from hepatitis C to hepatitis B – a virus that continues its global spread despite an available vaccine.
When I first started to work on hepatitis C virus (HCV) for my PhD, the general conviction was that it was a dangerous pathogen with very unsuccessful treatments. In the past years, this has completely changed; patients used to endure one year of treatment with severe side effects, but can now expect just three months of treatment, which is generally well tolerated. The truly impressive part here is that treatment success went up from below 50% to well over 90%. This has triggered the World Health Organisation (WHO) to aim for the eradication of all viral hepatitis by 2030 – a very ambitious goal. (more…)
Dr John Tregoning explains how the use of animals in science is properly regulated and why it’s so important to respiratory research, which could impact millions of lives.
Respiratory infection is one of the main causes of disease and death throughout the world, claiming 3 million deaths worldwide in 2016. The symptoms range from the mild (a runny nose) to the extremely serious (pneumonia, hospitalisation and respiratory failure). These infections have a large economic burden both directly in medical costs and indirectly in working days lost. They also represent a potential risk for causing major pandemics; one hundred years ago the 1918 flu outbreak led to the death of 50-100 million people, significantly more than the whole First World War. There is a clear need to understand why we get sick after respiratory infections and critically we need new drugs to reduce the burden of disease. For example, there is an urgent need for a new influenza vaccine that could prevent future pandemics. (more…)